The NRF2 pathway and proteostasis network, influencing each other and cooperating to protect cells from damage, emerge as appealing targets to mitigate the negative effects of fatty liver disease, insulin resistance, and obesity [23,24]. The gene discussed is NFE2L2; the disease is obesity disorder.